The Central Drugs Standard Control Organization (CDSCO), India's national drug regulatory authority, has undertaken the most significant regulatory modernization in its history during the first half of 2026. From introducing…
The United States imposed a sweeping 100% tariff on patented pharmaceutical imports on April 2, 2026, under Section 232 of the Trade Expansion Act. However, generic medicines — which make…
India's Central Drugs Standard Control Organisation (CDSCO) is embarking on the most significant regulatory restructuring in its history. In a move designed to strengthen pharmaceutical quality oversight and align with…
New Delhi, May 2026 — India now supplies nearly 20% of the world’s generic medicines, according to a comprehensive report from the Global Trade Research Initiative (GTRI). The report, released…